Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Combinations in Breast Cancer Therapy
Funmilola A. Fisusi, Emmanuel O. Akala
Pharmaceutical Nanotechnology (2019) Vol. 7, Iss. 1, pp. 3-23
Open Access | Times Cited: 377

Showing 1-25 of 377 citing articles:

Application of Nanomaterials in Biomedical Imaging and Cancer Therapy
Sarkar Siddique, James C. L. Chow
Nanomaterials (2020) Vol. 10, Iss. 9, pp. 1700-1700
Open Access | Times Cited: 307
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 117
The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 91
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
Daoyuan Chen, Xuecun Liu, Xiaoyan Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 59
Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy
Xiao Mi, Meigeng Hu, Mingran Dong, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 8337-8352
Open Access | Times Cited: 80
LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
Nicola d’Avanzo, Giulia Torrieri, Patrícia Figueiredo, et al.
International Journal of Pharmaceutics (2021) Vol. 597, pp. 120346-120346
Open Access | Times Cited: 77
Co‐delivery CPT and PTX prodrug with a photo/thermo‐responsive nanoplatform for triple‐negative breast cancer therapy
Wenhui Zhou, Xiaodong Ma, Jie Wang, et al.
Smart Medicine (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 65
Targeting Engineered Nanoparticles for Breast Cancer Therapy
Kumar Ganesan, Yan Wang, Fei Gao, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1829-1829
Open Access | Times Cited: 63
pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment
Yuanfen Liu, Yingchun Ran, Yu Ge, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 652-652
Open Access | Times Cited: 53
METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis
Enjie Li, Mingyue Xia, Yu Du, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 50
Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma
Soniya Kumbham, Milan Paul, Asif Mohd Itoo, et al.
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121479-121479
Closed Access | Times Cited: 47
Targeting lncRNA DDIT4‐AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy
Ting Jiang, Jiaojiao Zhu, Shilong Jiang, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 40
Application of aptamer-drug delivery system in the therapy of breast cancer
Rui Fan, Xufeng Tao, Xiaohan Zhai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114444-114444
Open Access | Times Cited: 34
Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 34
Current status and prospect of ZIF-based materials for breast cancer treatment
Yana Zeng, Donghui Liao, Xiangyang Kong, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 232, pp. 113612-113612
Closed Access | Times Cited: 28
The emerging role of PPAR-alpha in breast cancer
Zhiwen Qian, Lingyan Chen, Jiayu Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114420-114420
Open Access | Times Cited: 24
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 24
Drug-drug interactions prediction based on deep learning and knowledge graph: A review
Huimin Luo, Weijie Yin, Jianlin Wang, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109148-109148
Open Access | Times Cited: 16
Paclitaxel for breast cancer therapy: A review on effective drug combination modalities and nano drug delivery platforms
Masoumeh Kaveh Zenjanab, Sajjad Alimohammadvand, Abolfazl Doustmihan, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105567-105567
Closed Access | Times Cited: 15
Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells
Narges Dashti, Vajihe Akbari, Jaleh Varshosaz, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131971-131971
Closed Access | Times Cited: 13
Synergistic Viro-chemoimmunotherapy in Breast Cancer Enabled by Bioengineered Immunostimulatory Exosomes and Dual-Targeted Coxsackievirus B3
Amirhossein Bahreyni, Yasir Mohamud, Sanaz Ashraf Nouhegar, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4241-4255
Open Access | Times Cited: 12
The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer
Sukhmandeep Kaur, Patricia Mendonca, Karam F. A. Soliman
Nutrients (2024) Vol. 16, Iss. 15, pp. 2392-2392
Open Access | Times Cited: 10
Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy
Harneet Marwah, Hitesh Kumar Dewangan
Current Pharmaceutical Design (2024) Vol. 30, Iss. 37, pp. 2922-2936
Closed Access | Times Cited: 9
Neuromodulatory effect of troxerutin against doxorubicin and cyclophosphamide-induced cognitive impairment in rats: Potential crosstalk between gut–brain and NLRP3 inflammasome axes
Nada K. Gamal, Reem N. El‐Naga, Iriny M. Ayoub, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114216-114216
Closed Access | Times Cited: 1
Biomimetic Nanoparticles: A Revolutionary Approach to Breast Cancer Therapy Using Cell Membrane Coatings
Jyoti Chandra, Nagashekhara Molugulu, Garima Gupta, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106849-106849
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top